CorTec Announces First Human Implantation of a Brain-Computer Interface made in Germany
Summary
CorTec GmbH announced the first human implantation of its Brain Interchange BCI system, developed entirely in Germany. The procedure took place at Harborview Medical Center in Seattle under an FDA IDE. The closed-loop BCI records brain activity and delivers targeted electrical stimulation in real time to enhance neuroplasticity for stroke patient rehabilitation. The study is funded by the NIH.
Why it matters
This milestone marks Germany's entry into the implantable BCI market and demonstrates Europe's capability to develop competitive neurotechnology. CorTec's wireless, fully implantable system represents a significant advance in personalized neuromodulation therapies for stroke recovery.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial